Nitrase Therapeutics
- Website
- nitrasetx.com
- Total Funding
- $45.0M
- Last Round
- $45.0M Series AApr 2024
- Rounds
- 1
About
Protein nitrosylation platform for cancer and inflammation
Summary
It has raised $45.0M in total across 1 round, most recently a $45.0M Series A round in Apr 2024. Investors include Sofinnova Partners, AbbVie Ventures and Alexandria Venture Investments.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
